3 completed, 1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Magna Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study PSE 120 mg, CM 8 mg, Atr 0.36 mg, PSE 120 mg, CM 8 mg, Atr 0.24 mg, PSE 120 mg, CM 8 mg, Atr 0.12 mg - Rhinitis, Seasonal, Allergic | Phase 2 | Unknown | Magna Pharmaceuticals, Inc. | 125 | 2014-03-01 | 2014-05-30 |
| Study of AHIST in Seasonal Allergic Rhinitis Patients AHIST NDC#58407-012-01 - Rhinitis, Allergic, Seasonal | Phase 1 | Withdrawn | Magna Pharmaceuticals, Inc. | 2011-04-01 | 2014-03-06 | |
| Trial of STAHIST in Seasonal Allergic Rhinitis STAHIST, Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | Magna Pharmaceuticals, Inc. | 290 | 2011-03-01 | 2011-09-02 |
| Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects Placebo, STAHIST - Seasonal Allergic Rhinitis | Phase 2 | Completed | Magna Pharmaceuticals, Inc. | 100 | 2010-09-01 | 2014-03-26 |
| Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients STAHIST NDC #58407-536-01 - Rhinitis, Allergic, Seasonal | Phase 1 | Completed | Magna Pharmaceuticals, Inc. | 21 | 2009-10-01 | 2010-12-08 |
Rhinitis, Allergic, Seasonal (5) · Rhinitis (1)
Atropine (1) · Chlorpheniramine (1) · Proto-Oncogene Proteins c-raf (1) · Pseudoephedrine (1)
United States (5)